Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 228

1.

Adjuvant treatment of high-risk adult soft tissue sarcomas: a survey by the Italian Sarcoma Group.

Frustaci S, Berretta M, Comandone A, Bidoli E, De Paoli A, Gherlinzoni F, De Pas T, Barbieri E, Pertici M, Apice G, Picci P; Italian Sarcoma Group.

Tumori. 2006 Mar-Apr;92(2):92-7.

PMID:
16724686
[PubMed - indexed for MEDLINE]
2.

A phase II study of dose-intense ifosfamide plus epirubicin with hematopoietic growth factors for the treatment of patients with advanced soft tissue sarcomas; a novel sequential schedule.

Serrone L, Zeuli M, Gamucci T, Nardi M, Cognetti F.

Cancer Chemother Pharmacol. 2001 Mar;47(3):206-10.

PMID:
11320663
[PubMed - indexed for MEDLINE]
3.

Adjuvant chemotherapy for adult soft tissue sarcomas of the extremities and girdles: results of the Italian randomized cooperative trial.

Frustaci S, Gherlinzoni F, De Paoli A, Bonetti M, Azzarelli A, Comandone A, Olmi P, Buonadonna A, Pignatti G, Barbieri E, Apice G, Zmerly H, Serraino D, Picci P.

J Clin Oncol. 2001 Mar 1;19(5):1238-47.

PMID:
11230464
[PubMed - indexed for MEDLINE]
4.

Accelerated epirubicin-ifosfamide-dacarbazine regimen in patients with adult soft tissue sarcomas.

Michelotti A, Romanini A, Giannessi P, Bengala C, Conte P.

Am J Clin Oncol. 1996 Feb;19(1):78-81.

PMID:
8554042
[PubMed - indexed for MEDLINE]
5.

Phase I multicenter study of combined high-dose ifosfamide and doxorubicin in the treatment of advanced sarcomas. Swiss Group for Clinical Research (SAKK).

Leyvraz S, Bacchi M, Cerny T, Lissoni A, Sessa C, Bressoud A, Hermann R.

Ann Oncol. 1998 Aug;9(8):877-84.

PMID:
9789611
[PubMed - indexed for MEDLINE]
Free Article
6.

Chemotherapy, irradiation, and surgery for function-preserving therapy of primary extremity soft tissue sarcomas: initial treatment with ifosfamide, mitomycin, doxorubicin, and cisplatin plus granulocyte macrophage-colony-stimulating factor.

Edmonson JH, Petersen IA, Shives TC, Mahoney MR, Rock MG, Haddock MG, Sim FH, Maples WJ, O'Connor MI, Gunderson LL, Foo ML, Pritchard DJ, Buckner JC, Stafford SL.

Cancer. 2002 Feb 1;94(3):786-92.

PMID:
11857314
[PubMed - indexed for MEDLINE]
Free Article
7.

Efficacy of lenograstim on hematologic tolerance to MAID chemotherapy in patients with advanced soft tissue sarcoma and consequences on treatment dose-intensity.

Bui BN, Chevallier B, Chevreau C, Krakowski I, Peny AM, Thyss A, Maugard-Louboutin C, Cupissol D, Fargeot P, Bonichon F, et al.

J Clin Oncol. 1995 Oct;13(10):2629-36.

PMID:
7595717
[PubMed - indexed for MEDLINE]
8.

High-dose ifosfamide with hematopoietic growth factor support in advanced bone and soft tissue sarcomas.

Yalcin B, Pamir A, Buyukcelik A, Utkan G, Akbulut H, Demirkazik A, Icli F.

Exp Oncol. 2004 Dec;26(4):320-5.

PMID:
15627067
[PubMed - indexed for MEDLINE]
9.

A randomised phase II study on neo-adjuvant chemotherapy for 'high-risk' adult soft-tissue sarcoma.

Gortzak E, Azzarelli A, Buesa J, Bramwell VH, van Coevorden F, van Geel AN, Ezzat A, Santoro A, Oosterhuis JW, van Glabbeke M, Kirkpatrick A, Verweij J; E.O.R.T.C. Soft Tissue Bone Sarcoma Group and the National Cancer Institute of Canada Clinical Trials Group/Canadian Sarcoma Group.

Eur J Cancer. 2001 Jun;37(9):1096-103.

PMID:
11378339
[PubMed - indexed for MEDLINE]
10.

Granulocyte-macrophage colony-stimulating factor allows safe escalation of dose-intensity of chemotherapy in metastatic adult soft tissue sarcomas: a study of the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group.

Steward WP, Verweij J, Somers R, Spooner D, Kerbrat P, Clavel M, Crowther D, Rouesse J, Tursz T, Tueni E, et al.

J Clin Oncol. 1993 Jan;11(1):15-21.

PMID:
8418226
[PubMed - indexed for MEDLINE]
11.

Increasing dose of continuous infusion ifosfamide and fixed dose of bolus epirubicin in soft tissue sarcomas. A study of the Italian group on rare tumors.

Frustaci S, Buonadonna A, Romanini A, Comandone A, Dalla Palma M, Gamucci T, Verusio C, Lionetto R, Dani C, Casali P, Santoro A.

Tumori. 1999 Jul-Aug;85(4):229-33.

PMID:
10587022
[PubMed - indexed for MEDLINE]
12.
13.

Phase III trial of two investigational schedules of ifosfamide compared with standard-dose doxorubicin in advanced or metastatic soft tissue sarcoma: a European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group Study.

Lorigan P, Verweij J, Papai Z, Rodenhuis S, Le Cesne A, Leahy MG, Radford JA, Van Glabbeke MM, Kirkpatrick A, Hogendoorn PC, Blay JY; European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group Study.

J Clin Oncol. 2007 Jul 20;25(21):3144-50.

PMID:
17634494
[PubMed - indexed for MEDLINE]
Free Article
14.

Dose-intensive chemotherapy with ifosfamide, epirubicin, and filgrastim for adult patients with metastatic or locally advanced soft tissue sarcoma: a phase II study.

Reichardt P, Tilgner J, Hohenberger P, Dörken B.

J Clin Oncol. 1998 Apr;16(4):1438-43.

PMID:
9552049
[PubMed - indexed for MEDLINE]
15.

High-dose ifosfamide in bone and soft tissue sarcomas: results of phase II and pilot studies--dose-response and schedule dependence.

Patel SR, Vadhan-Raj S, Papadopolous N, Plager C, Burgess MA, Hays C, Benjamin RS.

J Clin Oncol. 1997 Jun;15(6):2378-84.

PMID:
9196153
[PubMed - indexed for MEDLINE]
16.

Ifosfamide plus epirubicin at escalating doses in the treatment of locally advanced and/or metastatic sarcomas.

Toma S, Palumbo R, Canavese G, Albanese E, Cantoni E, Barisone A, Reggiardo G, Rosso R, Santi L.

Cancer Chemother Pharmacol. 1993;31 Suppl 2:S222-7.

PMID:
8453703
[PubMed - indexed for MEDLINE]
17.

Neoadjuvant chemotherapy with high-dose Ifosfamide, high-dose methotrexate, cisplatin, and doxorubicin for patients with localized osteosarcoma of the extremity: a joint study by the Italian and Scandinavian Sarcoma Groups.

Ferrari S, Smeland S, Mercuri M, Bertoni F, Longhi A, Ruggieri P, Alvegard TA, Picci P, Capanna R, Bernini G, Müller C, Tienghi A, Wiebe T, Comandone A, Böhling T, Del Prever AB, Brosjö O, Bacci G, Saeter G; Italian and Scandinavian Sarcoma Groups.

J Clin Oncol. 2005 Dec 1;23(34):8845-52. Epub 2005 Oct 24.

PMID:
16246977
[PubMed - indexed for MEDLINE]
Free Article
18.

High-dose ifosfamide with mesna and granulocyte-colony-stimulating factor (recombinant human G-CSF) in patients with unresectable malignant mesothelioma.

Talbot SM, Rankin C, Taub RN, Balcerzak SP Jr, Bhoopalam N, Chapman RA, Baker LH, Middleman EL, Antman KH.

Cancer. 2003 Jul 15;98(2):331-6.

PMID:
12872353
[PubMed - indexed for MEDLINE]
Free Article
19.

[Neoadjuvant radiochemotherapy in soft tissue sarcomas. Optimization of local functional tumor control].

Sauer R, Schuchardt U, Hohenberger W, Wittekind C, Papadopoulos T, Grabenbauer GG, Fietkau R.

Strahlenther Onkol. 1999 Jun;175(6):259-66. German.

PMID:
10392166
[PubMed - indexed for MEDLINE]
20.

Phase II trial of neoadjuvant vincristine, ifosfamide, and doxorubicin with granulocyte colony-stimulating factor support in children and adolescents with advanced-stage nonrhabdomyosarcomatous soft tissue sarcomas: a Pediatric Oncology Group Study.

Pappo AS, Devidas M, Jenkins J, Rao B, Marcus R, Thomas P, Gebhardt M, Pratt C, Grier HE.

J Clin Oncol. 2005 Jun 20;23(18):4031-8. Epub 2005 Mar 14.

PMID:
15767644
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk